JCR Pharmaceuticals - About the company
JCR Pharmaceuticals is a public company based in Hyogo (Japan), founded in 1975. It operates as a Manufactures and commercializes biosimilars and cell therapies. JCR Pharmaceuticals has raised an undisclosed amount in funding.
Company Details
JCR Pharmaceuticals manufactures and commercializes biosimilars and cell therapies. It has three products on the Japanese market. Temcell is an allogeneic mesenchymal stem cell product. It also markets recombinant human growth hormone and recombinant erythropoietin. It has seven other recombinant proteins in various stages of clinical development.
- Registered Address
- 3-19 Kasuga-cho, Ashiya, Hyogo
Legal entities associated with JCR Pharmaceuticals
JCR Pharmaceuticals is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Jcr Pharmaceuticals Co Ltd CIN: 4552 , Japan, Active | Sep 01, 1975 | - | - | - |
JCR Pharmaceuticals's IPO details
JCR Pharmaceuticals got listed on Mar 18, 2011.
Click here to take a look at JCR Pharmaceuticals's IPO in detail
Sign up to download JCR Pharmaceuticals' company profile
JCR Pharmaceuticals's funding and investors
JCR Pharmaceuticals has raised funding over 1 round. Its latest funding round was a Post IPO round on Mar 12, 2008 for $*****. 1 investor participated in its latest round. JCR Pharmaceuticals has 2 institutional investors.
Here is the list of recent funding rounds of JCR Pharmaceuticals:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 12, 2008 | 4958105 | Post IPO | 5908942 | 5294497 | 7659805 | 1153618 |
View details of JCR Pharmaceuticals's funding rounds and investors
JCR Pharmaceuticals' founders and board of directors
Founder? Claim ProfileJCR Pharmaceuticals' employee count trend
JCR Pharmaceuticals has 141 employees as of May 26. Here is JCR Pharmaceuticals's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
JCR Pharmaceuticals's Investments and acquisitions
JCR Pharmaceuticals has made 1 investment in MYCENAX and acquired ArmaGen.Reports related to JCR Pharmaceuticals
Here is the latest report on JCR Pharmaceuticals's sector:
News related to JCR Pharmaceuticals
Media has covered JCR Pharmaceuticals for a total of 5 events in the last 1 year, 2 of them have been about company updates and 2 about partnerships.
•
•
•
•
JCR Pharma & Alexion Achieve Milestone in Neurodegenerative Disease ProgramBusiness Wire•Sep 19, 2025•JCR Pharmaceuticals, Alexion
•
JCR Pharma Presents Long-Term Clinical Data on Pabinafusp Alfa for MPS II at ICIEM 2025Business Wire•Sep 08, 2025•JCR Pharmaceuticals
•
MEDIPAL HOLDINGS & JCR Pharmaceuticals Sign Licensing Agreement for JR-479Business Wire•Sep 02, 2025•JCR Pharmaceuticals, MEDIPAL
•
Acumen and JCR partner on brain delivery therapy for Alzheimer’s
Pharmaceutical Technology•Jul 16, 2025•Acumen Pharmaceuticals, JCR Pharmaceuticals
•
•
•
JCR Pharma and Alexion partner on JUST-AAV gene therapy platform
Pharmaceutical Technology•Jul 09, 2025•JCR Pharmaceuticals, Alexion, AstraZeneca
Are you a Founder ?
FAQs about JCR Pharmaceuticals
Explore our recently published companies
- Solar - Indore based, 1994 founded, Unfunded company
- Bina Punjani - India based, 2011 founded, Unfunded company
- Aviator - India based, Unfunded company
- Admit Beacon - India based, 2021 founded, Unfunded company
- Origin Itfs - Chennai based, 1993 founded, Unfunded company
- 1Win - India based, 2026 founded, Unfunded company